Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (56)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

2023

  1. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

    Journal of Translational Medicine, Vol. 21, Núm. 1

  3. Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer

    EMBO Reports, Vol. 24, Núm. 8

  4. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

  5. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. Deep learning-based lesion subtyping and prediction of clinical outcomes in COVID-19 pneumonia using chest CT

    Scientific Reports, Vol. 12, Núm. 1

  2. Deep-learning characterization and quantification of COVID-19 pneumonia lesions from chest CT images

    Progress in Biomedical Optics and Imaging - Proceedings of SPIE

  3. Generation of NKX2.5GFP Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

2021

  1. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989

  2. Delta-radiomics signature for prediction of survival in advanced nsclc patients treated with immunotherapy

    Proceedings - International Symposium on Biomedical Imaging

  3. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

  4. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  5. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

2020

  1. Design and implementation of predictive models based on radiomics to assess response to immunotherapy in non-small-cell lung cancer

    XXXVIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. CASEIB 2020: Libro de actas

  2. MiR-9-5p protects from kidney fibrosis by metabolic reprogramming

    FASEB Journal, Vol. 34, Núm. 1, pp. 410-431

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Corticosteroides inhalados y cáncer de pulmón en la EPOC

    Archivos de bronconeumologia

  3. Inhaled Corticosteroids and Lung Cancer in COPD

    Archivos de Bronconeumologia